← SynDRA
reboxetine
SynDRA canonical compound SYN0041507 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | SLC6A2 |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
| Indication | depression |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- SLC6A2
- HTR2C
- HTR6
- KCNJ3
- KCNJ5
- KCNJ6
- NET
- SLC6A3
- SLC6A4
- Slc6a2
- Slc6a4
Mechanisms of action (all sources)
- adrenergic receptor antagonist
Drug classes
- Adrenergic Agents
- Adrenergic Uptake Inhibitors
- Antidepressive Agents
- Central Nervous System Agents
- Membrane Transport Modulators
- Neurotransmitter Agents
- Neurotransmitter Uptake Inhibitors
- Psychotropic Drugs
ATC classes
Cross-references
Synonyms
- reboxetine mesilate
- reboxetine mesylate
- edronax
- norebox
- reboxitine
- Reboxetina
- reboxetinum
- RefChem:930594
- N06AX18
- DTXCID301471552
- Morpholine, 2-((R)-(2-ethoxyphenoxy)phenylmethyl)-, (2R)-
- (2S)-2-((S)-2-ethoxyphenoxy(phenyl)methyl)morpholine
- Edronax
- Reboxetine [INN]
- (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine
- (2r)-2-[(R)-(2-Ethoxyphenoxy)(Phenyl)methyl]morpholine
- Reboxetine (INN)
- (R)-2-((R)-(2-ethoxyphenoxy)(phenyl)methyl)morpholine
- Reboxitine
- (R,R)-Reboxetine
- Reboxetine [INN:BAN]
- UNII-947S0YZ36I
- Reboxe- tine
- Reboxetinemesylate
- HSDB 7701
- Edronax (TN)
- Morpholine, 2-[(2-ethoxyphenoxy)phenylmethyl]-, (R*,R*)-
- REBOXETINE [MI]
- REBOXETINE [HSDB]
- REBOXETINE [VANDF]
- (R,R)-(-)-Reboxetine
- REBOXETINE [WHO-DD]
- SCHEMBL34533
- orb1701944
- SCHEMBL29930185
- (2R)-2-[(R)-(2-ethoxyphenoxy)-phenyl-methyl]morpholine
- CHEBI:135342
- BDBM388642
Look up reboxetine in the interactive SynDRA portal →